Cite
HARVARD Citation
Evans, E. et al. (n.d.). Evidence that semaphorin 4D is upregulated in neurons in Huntington's and Alzheimer's diseases: Effects of a SEMA4D blocking antibody on FDG‐PET in a clinical trial, and treatment rationale for its use in AD. Alzheimer's & dementia. p. n/a. [Online].